DK1299365T3 - 2-aminothiazolinderivater og deres anvendelse som inhibitorer for NO-synthase - Google Patents

2-aminothiazolinderivater og deres anvendelse som inhibitorer for NO-synthase

Info

Publication number
DK1299365T3
DK1299365T3 DK01943580T DK01943580T DK1299365T3 DK 1299365 T3 DK1299365 T3 DK 1299365T3 DK 01943580 T DK01943580 T DK 01943580T DK 01943580 T DK01943580 T DK 01943580T DK 1299365 T3 DK1299365 T3 DK 1299365T3
Authority
DK
Denmark
Prior art keywords
synthase
inhibitors
aminothiazoline
derivatives
aminothiazoline derivatives
Prior art date
Application number
DK01943580T
Other languages
English (en)
Inventor
Jean-Christophe Carry
Dominique Damour
Serge Mignani
Eric Bacque
Michel Tabart
Claude Guyon
Antony Bigot
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK1299365T3 publication Critical patent/DK1299365T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK01943580T 2000-06-09 2001-06-07 2-aminothiazolinderivater og deres anvendelse som inhibitorer for NO-synthase DK1299365T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0007397A FR2810037B1 (fr) 2000-06-09 2000-06-09 Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible

Publications (1)

Publication Number Publication Date
DK1299365T3 true DK1299365T3 (da) 2006-02-06

Family

ID=8851134

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01943580T DK1299365T3 (da) 2000-06-09 2001-06-07 2-aminothiazolinderivater og deres anvendelse som inhibitorer for NO-synthase

Country Status (28)

Country Link
EP (1) EP1299365B1 (da)
JP (1) JP4238026B2 (da)
KR (1) KR20030025931A (da)
CN (1) CN1202096C (da)
AP (1) AP2002002708A0 (da)
AR (1) AR029937A1 (da)
AT (1) ATE305460T1 (da)
AU (1) AU2001266124A1 (da)
BR (1) BR0111986A (da)
CA (1) CA2411760C (da)
DE (1) DE60113689T2 (da)
DK (1) DK1299365T3 (da)
DZ (1) DZ3367A1 (da)
EA (1) EA200300010A1 (da)
EC (1) ECSP024375A (da)
ES (1) ES2248347T3 (da)
FR (1) FR2810037B1 (da)
HR (1) HRP20020970A2 (da)
HU (1) HUP0301000A2 (da)
IL (1) IL153328A0 (da)
MA (1) MA25814A1 (da)
MX (1) MXPA02012071A (da)
NO (1) NO20025884L (da)
NZ (1) NZ522968A (da)
OA (1) OA12286A (da)
PL (1) PL360285A1 (da)
WO (1) WO2001094325A1 (da)
ZA (1) ZA200209769B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2337654T3 (es) * 2001-09-26 2010-04-28 Yissum Research Development Company Of The Hebrew University Of Jerusalem Esfingolipidos.
JP4342309B2 (ja) * 2001-11-09 2009-10-14 アベンティス・ファーマ・ソシエテ・アノニム 誘導型ｎｏ−シンターゼ阻害剤としての２−アミノ−４−ピリジルメチル−チアゾリン誘導体の使用
ES2250731T3 (es) * 2001-11-09 2006-04-16 Aventis Pharma S.A. Derivados de 2-amino-4-heteroariletil tiazolina y su utilizacion como inhibidores de no-sintasa inductible.
PT1446393E (pt) * 2001-11-09 2006-05-31 Aventis Pharma Sa Derivados de 2-amino-tiazolina e sua utilizacao como inibidores da sintase de no indutivel
WO2003075922A1 (en) * 2002-03-14 2003-09-18 Dainippon Pharmaceutical Co., Ltd. Nitrogen monoxide synthase inhibitors
AU2003257300B2 (en) 2002-08-07 2010-01-21 Neuraxon Inc. Amino benzothiazole compounds with NOS inhibitory activity
DE10332560B4 (de) * 2003-07-11 2010-07-08 Chiracon Gmbh Verfahren zur Herstellung von ß- Heteroaryl-2-alanin-Verbindungen über 2-Amino-2-(heteroarylmethyl)-carbonsäure-Verbindungen
KR101800507B1 (ko) 2015-09-18 2018-01-18 주식회사 이엔이티아이 자동세척 스크린과 식물정화장치를 활용하여 지속적으로 유입되는 생활하수나 공정폐수가 유입되는 오염하천정화를 위한 방법 및 그 장치

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066662A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors
EP0670720A1 (en) * 1992-11-27 1995-09-13 The Wellcome Foundation Limited Enzyme inhibitors
KR100342275B1 (ko) * 1993-10-21 2002-12-05 지.디. 썰 엘엘씨 산화질소신타제저해제로서유용한아미디노유도체
AU4149696A (en) * 1994-11-15 1996-06-06 Merck & Co., Inc. Substituted heterocycles as inhibitors of nitric oxide synthase
EP1251130B1 (en) * 1999-12-24 2005-02-16 Kyowa Hakko Kogyo Co., Ltd. Fused purine derivatives

Also Published As

Publication number Publication date
FR2810037A1 (fr) 2001-12-14
JP4238026B2 (ja) 2009-03-11
CN1202096C (zh) 2005-05-18
AP2002002708A0 (en) 2002-12-31
HUP0301000A2 (hu) 2003-08-28
ECSP024375A (es) 2003-02-06
BR0111986A (pt) 2003-04-01
OA12286A (en) 2006-05-12
EA200300010A1 (ru) 2003-06-26
DE60113689T2 (de) 2006-07-13
AR029937A1 (es) 2003-07-23
NZ522968A (en) 2005-07-29
AU2001266124A1 (en) 2001-12-17
IL153328A0 (en) 2003-07-06
MA25814A1 (fr) 2003-07-01
HK1057900A1 (en) 2004-04-23
CN1444572A (zh) 2003-09-24
ES2248347T3 (es) 2006-03-16
NO20025884L (no) 2003-01-29
DE60113689D1 (de) 2006-02-09
ATE305460T1 (de) 2005-10-15
CA2411760C (fr) 2009-12-29
NO20025884D0 (no) 2002-12-06
PL360285A1 (en) 2004-09-06
HRP20020970A2 (en) 2005-02-28
JP2003535853A (ja) 2003-12-02
EP1299365A1 (fr) 2003-04-09
KR20030025931A (ko) 2003-03-29
CA2411760A1 (fr) 2001-12-13
EP1299365B1 (fr) 2005-09-28
WO2001094325A1 (fr) 2001-12-13
MXPA02012071A (es) 2004-09-10
DZ3367A1 (fr) 2001-12-13
FR2810037B1 (fr) 2004-04-23
ZA200209769B (en) 2004-03-02

Similar Documents

Publication Publication Date Title
NO20026010D0 (no) Substituerte quinazolinderivater og deres anvendelse som inhibitorer
DK1347955T3 (da) Nye mandelsyrederivater og deres anvendelse som throbin-hæmmere
DK1480962T3 (da) 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer
DK1373224T3 (da) Nye spirotricykliske derivater og deres anvendelse som phosphodiesterase 7 inhibitorer
NO20014409D0 (no) Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase
DK1556375T3 (da) Flavonderivater som inhibitorer af cyklinafhængige kinaser
NO20030867L (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
NO20030958L (no) Pyrazolderivater og deres anvendelse som proteinkinase inhibitorer
NO20023319L (no) Substituerte glutarimider og deres anvendelse som inhibitorer av IL-12-produksjonen
DK1289985T3 (da) Beta-carbolinderivater anvendelige som phosphodiesteraseinhibitorer
NO20031139L (no) 2-amino-2-alkyl-4-heksen- og heksynsyrederivater som er anvendbare som nitrogenoksidsyntaseinhibitorer
DK1223933T3 (da) 5-leddet derivater af heterocyklusser og deres anvendelse som monoaminoxidaseinhibitorer
PT1296981E (pt) Derivados substituidos da pirrolopiridinona uteis como inibidores da fosfodiesterase
NO20042719L (no) Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer
DK1317421T3 (da) 2-amino-2-alkyl-5-heptensyre- og heptynsyrederivater der er nyttige som nitrogenoxidsynthaseinhibitorer
DK1330455T3 (da) Hidtil ukendte 7-azaindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
NO20010479D0 (no) Tricykliske sulfonamider og deres derivater som inhibitorer av matriksmetalloproteinaser
DK1150996T3 (da) Nye amidinobenzylaminderivater og deres anvendelse som thrombin-inhibitorer
NO20023956D0 (no) Priperidin- og piperazinsubstituerte N-hydroksyformamider som inhibitorer av metalloproteinaser
DK1299365T3 (da) 2-aminothiazolinderivater og deres anvendelse som inhibitorer for NO-synthase
NO20030813D0 (no) Bifenylderivater og deres anvendelse som integrininhibitorer
NO20026164L (no) Benzoksazepinoner og deres anvendelse som squalen syntase inhibitorer
NO20022123D0 (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO20030243L (no) Nye forbindelser og deres anvendelse som glysintransportinhibitorer
DK1255757T3 (da) Aminosyreforbindelser og deres anvendelse som inhibitorer for NEP, ACE og ECE